Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide ...

Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...

Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient resources to ensure safe access to Wegovy. Novo Nordisk has announced ...

A recently published report by the Brookings Institute found that these foreign suppliers are making up their own standards for manufacturing "semaglutide," and Novo Nordisk's testing has revealed ...

(RTTNews) - Novo Nordisk announced a series of initiatives to further support patient access to FDA-approved Wegovy, or semaglutide, injection 2.4 mg as federal ban on mass compounding of ...

A recently published report by the Brookings Institute found that these foreign suppliers are making up their own standards for manufacturing "semaglutide," and Novo Nordisk's testing has revealed ...

PLAINSBORO, N.J., May 22, 2025 /PRNewswire/ -- Today, as the US Food and Drug Administration (FDA) grace period for mass compounding of "semaglutide" expires, Novo Nordisk announced a series of ...